This article considers how epidemiology has functioned as a form of resource extraction by tracing the work of Dr. Ray Newton Lawson, the founder of breast thermography and one of the first researchers to track breast cancer incidence within circumpolar Canada. By showing how Lawson was able to transform his ideas and observations about Inuit breast cancer risk into something medically, professionally, and financially useful, this article highlights the politics of epidemiological knowledge production, and the long-standing tendency of researchers to view Indigenous lands and bodies as “raw materials” to be exploited. It also draws attention to the enduring impact of Lawson’s research, as his new ways of representing northern disease patterns and breast tumor tissue have had long-lasting effects on how medical professionals and health systems “see” breast cancer and decide who should (and should not) have access to cancer screening technologies and other forms of preventative care.
Aim: In early-stage breast cancer, the axillary lymph nodes play a crucial role in determining the prognosis of the disease. The rate of lymph node involvement might be a more valuable prognostic factor than the number of positive lymph nodes. Therefore, we aimed to evaluate whether the lymph node ratio (LNR) is a superior prognostic indicator compared to the pathologic lymph node count in early-stage disease.
Aim: Breast cancer is the most common cancer in women and is a leading cause of cancer-related mortality. The role of neoadjuvant therapy (NAT) in conjunction with surgical intervention is becoming increasingly prominent in the field of oncology. NAT enhance the probability of breast-conserving surgery in cases of locally advanced breast cancer and in patients with metastatic or inoperable disease.
Aim: The prognostic factors and a nomogram applicable to breast cancer (BC) patients with bone metastasis (BM) who received first-line chemotherapy have not been extensively studied. This study aimed to identify prognostic factors and construct a prognostic nomogram to predict overall survival (OS) in this population.
Methods: Data for BC patients with BM undergoing first-line chemotherapy were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2016.
Aim: We report a case of proliferative myositis (PM) of the breast, which is the second reported in the English literature.
Case Presentation: A 49-year-old woman underwent surgery due to a fibroadenoma in the right and phyllodes tumor in the left breast. One month after these surgeries, a right breast mass rapidly grew at the surgical site, and biopsy did not provide a diagnosis.
